Maze Therapeutics, Inc. · NASDAQ:MAZE
Matrix Capital Management Company, LP's stake in Maze Therapeutics, Inc. fell to 3.50% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 13, 2025
Matrix Capital Management Company, LP's stake in Maze Therapeutics, Inc. fell to 3.50%, 1,653,684 shares, as a passive investor on Sep 30, 2025. Filed Nov 13, 2025 (Schedule 13G/A).
- Stake
- 3.50%
- Shares
- 1,653,684
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Matrix Capital Management Company, LP | 3.50% | 1,653,684 |
| DAVID E. GOEL | 3.50% | 1,653,684 |
Source
Related
- Maze Therapeutics, Inc.
- Matrix Capital Management Company, LP
- Maze Therapeutics, Inc. shareholders
- Schedule 13G · Matrix Capital Management Company, LP · May 14, 2025
- Form 4 · Bernstein Harold · Oct 2, 2026
- Form 4 · Coloma Jason V · Oct 2, 2026
- Form 4 · Dandekar Atul · Oct 1, 2026
- Form 4 · Bernstein Harold · Sep 8, 2026
- Form 4 · Bernstein Harold · Sep 4, 2026